Science + Tech

The latest progress on the Interdisciplinary Science and Engineering Building

A gray haze hung over Cleveland last week as smoke and soot from raging wildfires in western Canada swept over our region. Southwesterly winds carried harmful toxins and pollutants with them, resulting in an air quality advisory that warned those in sensitive groups to stay indoors to minimize the…

In collaboration with the Community Advisory Board (CAB), the CTSC is working to strengthen Community Engaged Research (CER) capacity across its institutional and community partners. To support this goal, we are developing a CER training that draws on core principles of community…

On April 26, 2025, Dr. Sarah Ronis, a Clinical & Translational Science (CTS) Research Program awardee and recent Co-Investigator on a 2024 Annual Pilot award with the Clinical and Translational Science Collaborative (CTSC) of Northern Ohio, shared important new research at the Pediatric…

Case Western Reserve University researchers combat deadly cancer with therapeutic vaccines

A generous commitment from longtime supporters accelerates research in materials innovation

Each academic year, the Translational Fellows Program (TFP)—supported by the Clinical and Translational Science Collaborative (CTSC)—trains a cohort of individuals in entrepreneurship and the translation of innovation into commercial ventures. Through the CTSC’s resources and network, Fellows…

Ica Manas-Zloczower Thomas W. and Nancy P. Seitz Professor of Advanced Materials and Energy, Department of Macromolecular Science and Engineering, Case School of Engineering Professor of chemical and biomedical engineering Area of Focus: sustainability, materials innovation, macromolecular…

When we think about protecting the oceans, Cleveland isn’t usually the first city that comes to mind. Yet, even from the shores of Lake Erie, our everyday decisions can ripple far beyond Ohio—and have real consequences for marine ecosystems across the globe. Peter Whiting To explain how…

Co-leader of Case CCC's Immune Oncology Program, David Wald, MD, PhD, has already improved the landscape of CAR T immunotherapy by developing an ultra-fast procedure that cuts CAR T cell manufacturing from two weeks to less than 24 hours. However, harvesting T cells to make CAR T therapy…